PURPOSE: About one-third of sporadic lung adenocarcinomas demonstrates biallelic inactivation of the LKB1 gene, but the timing of this event is not known. DESIGN: We performed LKB1 immunohistochemistry on 35 primary lung adenocarcinomas and 96 atypical adenomatous hyperplasias (AAH), a form of early glandular neoplasia from which some lung adenocarcinomas arise. RESULTS: In all cases, strong cytoplasmic staining was noted in the non-neoplastic epithelium lining the airways from the bronchi to the terminal bronchioles. There was a marked reduction in LKB1 staining in 9 of 35 (26%) adenocarcinomas and in 10 of 96 (10%) AAHs. When the AAHs were subclassified on the basis of cytoarchitectural atypia, loss of LKB1 expression was more frequent in the high-grade lesions (7 of 33, 21%) than low-grade lesions (3 of 63, 5%; P = 0.021). For the 21 adenocarcinomas where the genetic status was known, immunohistochemistry staining reliably reflected the activational state of the LKB1 gene (95% concordancy). CONCLUSIONS: In AAH, loss of LKB1 expression is strongly associated with severe dysplasia, suggesting that LKB1 inactivation may play a role in the critical transition from premalignant to malignant tumor growth.
PURPOSE: About one-third of sporadic lung adenocarcinomas demonstrates biallelic inactivation of the LKB1 gene, but the timing of this event is not known. DESIGN: We performed LKB1 immunohistochemistry on 35 primary lung adenocarcinomas and 96 atypical adenomatous hyperplasias (AAH), a form of early glandular neoplasia from which some lung adenocarcinomas arise. RESULTS: In all cases, strong cytoplasmic staining was noted in the non-neoplastic epithelium lining the airways from the bronchi to the terminal bronchioles. There was a marked reduction in LKB1 staining in 9 of 35 (26%) adenocarcinomas and in 10 of 96 (10%) AAHs. When the AAHs were subclassified on the basis of cytoarchitectural atypia, loss of LKB1 expression was more frequent in the high-grade lesions (7 of 33, 21%) than low-grade lesions (3 of 63, 5%; P = 0.021). For the 21 adenocarcinomas where the genetic status was known, immunohistochemistry staining reliably reflected the activational state of the LKB1 gene (95% concordancy). CONCLUSIONS: In AAH, loss of LKB1 expression is strongly associated with severe dysplasia, suggesting that LKB1 inactivation may play a role in the critical transition from premalignant to malignant tumor growth.
Authors: Yevgeniya A Byekova; Jennifer L Herrmann; Jianmin Xu; Craig A Elmets; Mohammad Athar Journal: Arch Biochem Biophys Date: 2011-01-25 Impact factor: 4.013
Authors: Kyle G Mitchell; Edwin R Parra; Jiexin Zhang; David B Nelson; Erin M Corsini; Pamela Villalobos; Cesar A Moran; Ferdinandos Skoulidis; Ignacio I Wistuba; Junya Fujimoto; Jack A Roth; Mara B Antonoff Journal: Ann Thorac Surg Date: 2020-05-19 Impact factor: 4.330
Authors: Regan M Memmott; Jose R Mercado; Colleen R Maier; Shigeru Kawabata; Stephen D Fox; Phillip A Dennis Journal: Cancer Prev Res (Phila) Date: 2010-09-01
Authors: S Matsumoto; R Iwakawa; K Takahashi; T Kohno; Y Nakanishi; Y Matsuno; K Suzuki; M Nakamoto; E Shimizu; J D Minna; J Yokota Journal: Oncogene Date: 2007-03-26 Impact factor: 9.867
Authors: Regan M Memmott; Joell J Gills; Melinda Hollingshead; Margaret C Powers; Zhiping Chen; Bruce Kemp; Alan Kozikowski; Phillip A Dennis Journal: Cancer Res Date: 2008-01-15 Impact factor: 12.701
Authors: Julien D F Licchesi; William H Westra; Craig M Hooker; Emi O Machida; Stephen B Baylin; James G Herman Journal: Carcinogenesis Date: 2008-02-28 Impact factor: 4.944